Streetbeat News

Stock Prices

CRD

Crawford & Company Common Stock (NYSE:CRD) reported Q3 earnings of $0.36 per share, beating the analyst consensus estimate of $0.26 by 38.46%. This is a 125% increase from the same period last year. However, the company's quarterly sales of $325.59 million missed the analyst consensus estimate of $331.10 million by 1.66%, though it's a 10.40% increase from last year.

Portfolio Pulse from bharat@benzinga.com

November 06, 2023 | 9:51 pm

HIMS

Hims & Hers Health, Inc. (NYSE:HIMS) reported mixed Q3 results with earnings missing analyst estimates but revenue beating expectations. The company also announced a $50 million share repurchase program and raised its full-year 2023 revenue guidance. Shares were up 6.54% in after-hours trading.

Portfolio Pulse from Ryan Gustafson

November 06, 2023 | 9:50 pm

NEO

NeoGenomics has projected its FY23 revenue to be between $585M and $592M, which is higher than the estimated $573.19M.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:49 pm

RAIL

FreightCar America (NASDAQ:RAIL) reported Q3 2023 losses of $(0.14) per share, missing the analyst consensus estimate of $(0.04) by 250 percent. This is a 33.33 percent increase over losses from the same period last year. The company also reported quarterly sales of $61.89 million, missing the analyst consensus estimate of $102.30 million by 39.50 percent, a 27.81 percent decrease from the same period last year.

Portfolio Pulse from totan@benzinga.com

November 06, 2023 | 9:48 pm

HIMS

Hims & Hers reported better-than-expected Q3 sales results and raised its FY23 guidance above estimates. The company also announced a $50 million share repurchase program, leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:48 pm

KE

Kimball Electronics (NASDAQ:KE) reported Q1 2024 earnings of $0.43 per share, in line with analyst consensus. This is a 13.16% increase YoY. However, the company's quarterly sales of $438.08M missed the analyst consensus estimate of $452.20M by 3.12%, though it's a 7.93% increase YoY.

Portfolio Pulse from totan@benzinga.com

November 06, 2023 | 9:47 pm

CWAN

Clearwater Analytics Holdings, Inc. (NYSE:CWAN) has announced the launch of a secondary public offering of 17 million shares of its Class A common stock. The shares are being resold on behalf of affiliates of Welsh, Carson, Anderson & Stowe, Warburg Pincus LLC, and Permira Advisers LLC. The company will not receive any proceeds from the sale. J.P. Morgan is acting as the underwriter and sole book-running manager for the offering.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:44 pm

VRTX

Vertex Pharmaceuticals has increased its FY23 product revenue guidance from $9.7B-$9.8B to approximately $9.85B.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:43 pm

ADEA

Adeia (NASDAQ:ADEA) reported Q3 earnings of $0.38 per share, beating the analyst consensus estimate of $0.26 by 46.15%. This is a 22.58% increase from the same period last year. The company also reported quarterly sales of $101.40 million, beating the analyst consensus estimate of $90.81 million by 11.66%. However, this is a 51.93% decrease from the same period last year.

Portfolio Pulse from bharat@benzinga.com

November 06, 2023 | 9:41 pm

CNM

Core & Main has announced the launch of a secondary public offering of 19 million shares by certain selling stockholders. The company also plans a concurrent share repurchase of 3.1 million shares.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:41 pm